Multidrug-resistant Acinetobacter infection refers to disease caused by A. baumannii strains exhibiting resistance to multiple antimicrobial agents, including carbapenems used as last-line therapy against multidrug-resistant Gram-negative bacteria [1]. The organism is characterized as a nosocomial pathogen capable of causing severe infections in critically ill patients [2].
Aperçu de la maladie
BactérienneInfection à Acinetobacter multirésistante
Multidrug-resistant Acinetobacter infection
Suivre cette maladie Comparer les pays Informations étayées par des preuves EN 5/7 sections · FR 5/7 sections Mis à jour le Oct 23, 2026
Multidrug-resistant Acinetobacter baumannii has attracted substantial scientific concern because of its extensive antimicrobial resistance and the resulting difficulty in eradicating infections in both hospital and community settings [1]. It is a nosocomial pathogen causing ventilator-associated and bloodstream infections in critically ill patients, and its spread as a multidrug-resistant strain is worrisome [2]. Reservoirs have also been reported in livestock and community environments, indicating a breadth of occurrence beyond hospitals [1].
Lire le profil clinique et épidémiologique complet 6
The pathogen employs attachment, biofilm formation, secretion of toxins, and low activation of inflammatory responses as mechanisms during infection [1]. Minocycline has been identified as a tetracycline of choice for such infections, with doxycycline also showing activity, though these are antimicrobial rather than descriptive clinical traits [3].
Multidrug-resistant A. baumannii is a worldwide problem, with emerging resistance driven by mobile genetic elements such as transposons, plasmids, and integrons leading to prevalent MDR and extensive drug-resistant strains [1]. Outbreaks linked to plasmid-mediated resistance and occurrences in livestock and community settings reveal large strain reservoirs inside and outside hospitals [1].
A. baumannii thrives in health-care environments through environmental persistence mechanisms including desiccation resistance, biofilm formation, and motility, facilitating its spread as a nosocomial pathogen [2]. Its plastic genome rapidly mutates under stress, and recently identified virulence factors such as secretion systems and surface glycoconjugates support successful host infection [2].
Control of extensive drug-resistant A. baumannii infections requires proper monitoring and prevention measures according to review evidence [1].
- 1 Ibrahim S et al. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol Biol Rep. 2021 Oct. PMID: 34460060. doi: 10.1007/s11033-021-06690-6. PubMed: https://pubmed.ncbi.nlm.nih.gov/34460060/
- 2 Harding CM et al. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol. 2018 Feb. PMID: 29249812. doi: 10.1038/nrmicro.2017.148. PubMed: https://pubmed.ncbi.nlm.nih.gov/29249812/
- 3 Singh S et al. Minocycline and Doxycycline: More Than Antibiotics. Curr Mol Pharmacol. 2021. PMID: 33568043. doi: 10.2174/1874467214666210210122628. PubMed: https://pubmed.ncbi.nlm.nih.gov/33568043/
Chargement des données actuelles…
Tendances nationales
Choisissez le pays, la source et la mesure ; chaque courbe conserve sa période et sa définition de déclaration.
Chargement des données…
Couverture des données
Pays et régions déclarants
La carte montre la couverture déclarée. Choisissez une mesure ou ouvrez un lieu coloré pour consulter ses données.
Chargement des données actuelles…
Profil de surveillance
Saisonnalité du pays sélectionné
Consultez les valeurs mensuelles d’un pays par année. Les cases vides indiquent une valeur non publiée.
Chargement des alertes officielles…
Téléchargement et méthodes
Choisissez une période et téléchargez les fichiers CSV, JSON ou XLSX.